Mapping the emotional and social toll of pancreatic cancer treatment
NCT ID NCT04427761
First seen Jul 02, 2026 · Last updated Jul 02, 2026
Summary
This study explores the personal and social changes people with pancreatic cancer face while undergoing chemotherapy. Researchers will survey 55 patients about physical, emotional, social, and spiritual shifts at the start of treatment and again 4-6 weeks later. The goal is to better understand these transitions so healthcare teams can offer more tailored support.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could help doctors and nurses better support pancreatic cancer patients through the challenges of chemotherapy.
What could go wrong
This is a small, observational study with only 55 participants, so findings may not apply to all patients. It measures experiences, not treatment effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- LIVELONG Trial: Ablative Therapy for GI Cancers NCT06101277
- SPECT Imaging Targeting LRRC15 in Tumors - NCT07651020
- ICG Fluorescence-Guided Pancreatic Surgery Trial NCT07656571
- ES502 for Advanced Pancreatic Cancer Trial NCT07649928
- Lidocaine Infusion in Pancreatic Cancer Trial NCT04048278
- Occupational Risks for Biliary & Pancreatic Canc NCT07668024
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, New York, 10065, United States